13F HOLDINGS REPORT (Amended)
Caligan Partners LP
Quarter ended Q2 2023 · Filed May 15, 2023 · Accession 0001814554-23-000005
Total Value
$120.2M
Positions
11
Other Managers
0
Confidential Omitted
No
Holdings (11)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | LIQUIDIA CORP | LQDA | 9,243,627 | $58.9M | 49.00% |
| 2 | ANIKA THERAPEUTICS INC | ANIK | 591,675 | $17.5M | 14.58% |
| 3 | EVOLUS INC | EOLS | 1,740,700 | $13.1M | 10.88% |
| 4 | ADMA BIOLOGICS INC | ADMA | 2,676,093 | $10.4M | 8.64% |
| 5 | STANDARD BIOTOOLS INC | LAB | 8,576,799 | $10.0M | 8.35% |
| 6 | VERONA PHARMA PLC | 925050106 | 183,064 | $4.8M | 3.98% |
| 7 | SOCIETAL CDMO INC | 75629F109 | 1,603,214 | $2.4M | 1.99% |
| 8 | EYEPOINT PHARMACEUTICALS INC | EYPT | 435,298 | $1.5M | 1.27% |
| 9 | ALIMERA SCIENCES INC | 016259202 | 478,777 | $1.3M | 1.08% |
| 10 | JAZZ PHARMACEUTICALS PLC | JAZZ | 1,000 | $159,310 | 0.13% |
| 11 | AGIOS PHARMACEUTICALS INC | AGIO | 4,333 | $121,671 | 0.10% |